Association between LDL particle size and postprandial increase of remnant-like particles in Japanese type 2 diabetic patients

Diabetes Research and Clinical Practice

Volumn 66, Issue 3, 2004, Pages 245-252

  Takayanagi, Naoko ^a   Onuma, Tomio ^b   Kato, Shinobu ^a   Nishiyama, Kyoko ^a   Nomiyama, Takashi ^a   Kawamori, Ryuzo ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO TOKYO KOTO GERIATRIC MEDICAL CENTER   (Japan)

Author keywords

Dense LDL; Postprandial lipoprotein metabolism; Remnant lipoproteins; Remnant like particles (RLP); Small; Type 2 diabetes mellitus

Indexed keywords

CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARTICLE SIZE; PROTEIN BLOOD LEVEL; TEST MEAL;

ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LIPOPROTEINS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PARTICLE SIZE; POSTPRANDIAL PERIOD; TRIGLYCERIDES;

EID: 7944228124     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2004.04.002     Document Type: Article

References (35)

1. Kannel W.B. Lipids, diabetes, and coronary heart disease: insights from the Framingham Study. Am. Heart J. 110:1985;1100-1107
2. Stamler J., Vaccaro O., Neaton J.D., Wentworth D. For the multiple risk factor intervention trial research group. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care. 16:1993;434-444
3. Garcia M.J., McNamara P.M., Gordon T., Kannel W.B. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes. 23:1974;105-111
4. Austin M.A. Small, dense low-density lipoprotein as a risk factor for coronary heart disease. Int. J. Clin. Lab. Res. 24:1994;187-192
5. Austin M.A., King M.C., Vranizan K.M., Krauss R.M. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation. 82:1990;495-506
6. Tan C.E., Chew L.S., Chio L.F., Tai E.S., Lim H.S., Lim S.C., et al. Cardiovascular risk factors and LDL subfraction profile in type 2 diabetes mellitus subjects with good glycaemic control. Diabetes Res. Clin. Pract. 51:2001;107-114
7. Gray R.S., Robbins D.C., Wang W., Yeh J.L., Fabsitz R.R., Cowan L.D., et al. Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American indians. The strong heart study. Arterioscler. Thromb. Vasc. Biol. 17:1997;2713-2720
8. Selby J.V., Austin M.A., Newman B., Zhang D., Quesenberry C.P. Jr., Mayer E.J., et al. LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation. 88:1993;381-387
9. Stewart M.W., Laker M.F., Dyer R.G., Game F., Mitcheson J., Winocour P.H., et al. Lipoprotein compositional abnormalities and insulin resistance in type II diabetic patients with mild hyperlipidemia. Arterioscler. Thromb. 13:1993;1046-1052
10. Fontbonne A., Eschwege E., Cambien F., Richard J.L., Ducimetiere P., Thibult N., et al. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia. 32:1989;300-304
11. De Man F.H., Cabezas M.C., Van Barlingen H.H., Erkelens D.W., De Bruin T.W. Triglyceride-rich lipoproteins in non-insulin-dependent diabetes mellitus: postprandial metabolism and relation to premature atherosclerosis. Eur. J. Clin. Invest. 26:1996;89-108
12. Lahdenperä S., Syvänne M., Kahri J., Taskinen M.R. Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides. Diabetologia. 39:1996;453-461
13. Karpe F., Tornvall P., Olivecrona T., Steiner G., Carlson L.A., Hamsten A. Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein. Atherosclerosis. 98:1993;33-49
14. Tan K.C., Cooper M.B., Ling K.L., Griffin B.A., Freeman D.J., Packard C.J., et al. Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance. Atherosclerosis. 113:1995;273-287
15. Hirano T., Oi K., Sakai S., Kashiwazaki K., Adachi M., Yoshino G. High prevalence of small dense LDL in diabetic nephropathy is not directly associated with kidney damage: a possible role of postprandial lipemia. Atherosclerosis. 141:1998;77-85
16. Tanaka A., Tomie N., Nakano T., Nakajima K., Yui K., Tamura M., et al. Measurement of postprandial remnant-like particles (RLPs) following a fat-loading test. Clin. Chim. Acta. 275:1998;43-52
17. Schreuder P.C., Twickler T.B., Wang T., Nakajima K., Erkelens D.W., Dallinga-Thie G.M. Isolation of remnant particles by immunoseparation: a new approach for investigation of postprandial lipoprotein metabolism in normolipidemic subjects. Atherosclerosis. 157:2001;145-150
18. Kugiyama K., Doi H., Takazoe K., Kawano H., Soejima H., Mizuno Y., et al. Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation. 99:1999;2858-2860
19. Patsch J.R., Miesenböck G., Hopferwieser T., Mühlberger V., Knapp E., Dunn J.K., et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler. Thromb. 12:1992;1336-1345
20. Kato S., Onuma T., Takayanagi N., Nomiyama T., Ogiwara T., Tanaka Y., et al. Postprandial increase in atherogenic remnantlipoprotein in type 2 diabetes mellitus with fasting normolipidemia - an association with metabolic abnormalities. Diabetes. 48:1999;1104
21. Nakajima K., Saito T., Tamura A., Suzuki M., Nakano T., Adachi M., et al. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apoB-100 and anti apoA-I immunoaffinity mixed gels. Clin. Chim. Acta. 223:1993;53-71
22. Krauss R.M., Burke D.J. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J. Lipid Res. 23:1982;97-104
23. Ohmura H., Mokuno H., Sawano M., Hatsumi C., Mitsugi Y., Watanabe Y., et al. Lipid compositional differences of small, dense low-density lipoprotein particle influence its oxidative susceptibility: possible implication of increased risk of coronary artery disease in subjects with phenotype B. Metabolism. 51:2002;1081-1087
24. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultra centrifuge. Clin. Chem. 18:1972;499-502
25. Lemieux I., Couillard C., Pascot A., Bergeron N., Prud'homme D., Bergeron J., et al. The small, dense LDL phenotype as a correlate of postprandial lipemia in men. Atherosclerosis. 153:2000;423-432
26. Goldschmid M.G., Barrett-Connor E., Edelstein S.L., Wingard D.L., Cohn B.A., Herman W.H. Dyslipidemia and ischemic heart disease mortality among men and women with diabetes. Circulation. 89:1994;991-997
27. Mero N., Malmstrom R., Steiner G., Taskinen M.R., Syvanne M. Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease. Atherosclerosis. 150:2000;167-177
28. Tkáč I., Kimball B.P., Lewis G., Uffelman K., Steiner G. The severity of coronary atherosclerosis in type 2 diabetes mellitus is related to the number of circulating triglyceride-rich lipoprotein particles. Arterioscler. Thromb. Vasc. Biol. 17:1997;3633-3638
29. Zilversmit D.B. Atherogenesis: a postprandial phenomenon. Circulation. 60:1979;473-485
30. Karpe F., Steiner G., Uffelman K., Olivecrona T., Hamsten A. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis. 106:1994;83-97
31. Attia N., Durlach V., Paul J.L., Soni T., Betoulle D., GirardGloba A. Modulation of low density lipoprotein subclasses by alimentary lipemia in control and normotriglyceridemic non-insulin-dependent diabetic subjects. Atherosclerosis. 113:1995;197-209
32. Okazaki M., Usui S., Toda N., Nakano T., Nakajima K. Relation between RLP-triglyceride to RLP-cholesterol ratio and particle size distribution in RLP-cholesterol profiles by HPLC. Clin. Chim. Acta. 296:2000;135-149
33. Taskinen M.R. Pathogenesis of dyslipidemia in type 2 diabetes. Exp. Clin. Endocrinol. Diabetes. 109:2001;S180-S188
34. Lewis G.F. Fatty acid regulation of very low density lipoprotein production. Curr. Opin. Lipidol. 8:1997;146-153
35. Nikkilä E.A., Huttunen J.K., Ehnholm C. Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism. Diabetes. 26:1977;11-21